Reddoch James F.

EVP & Chief Scientific Officer at RPRX

Sold, on record
$39.2M
Dollars the filings state
Form 4 sales
14
Latest Sep 28, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • RPRXRoyalty Pharma plcEVP & Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale RPRXPlan not stated
    Jul 8, 2021 2021

    Sold 73,117 shares at $42.19 ($3.1M)

    Reddoch James F., EVP, Research & Investments

    Sold 5.8% of holdings ($53.6M position)1.2M shares left1.4x usual sizeFiling

  2. 2 Form 4 sale RPRXPlan not stated
    Jul 14, 2021 +6 days

    Sold 17,934 shares at $42.01 ($753k)

    Reddoch James F., EVP, Research & Investments

    Sold 1.5% of holdings ($50.3M position)1.2M shares left0.3x usual sizeFiling

  3. 3 Form 4 sale RPRXPlan not stated
    Jul 26, 2021 +12 days

    Sold 8,949 shares at $39.78 ($356k)

    Reddoch James F., EVP, Research & Investments

    Sold 0.8% of holdings ($46.9M position)1.2M shares left0.2x usual sizeFiling

  4. 4 Form 4 sale RPRXPlan not stated
    Jul 26, 2021 same day

    Sold 8,949 shares at $39.78 ($356k)

    Reddoch James F., EVP, Research & Investments

    Sold 0.8% of holdings ($46.9M position)1.2M shares left0.2x usual sizeFiling

  5. 5 Form 4 sale RPRXPlan not stated
    May 19, 2022 +297 days

    Sold 75,000 shares at $40.44 ($3M)

    Reddoch James F., EVP & Chief Scientific Officer

    Sold 6.4% of holdings ($47.3M position)1.1M shares left1.6x usual sizeFiling

  6. 6 Form 4 sale RPRXPlan not stated
    May 27, 2022 +8 days

    Sold 75,000 shares at $41.08 ($3.1M)

    Reddoch James F., EVP & Chief Scientific Officer

    Sold 6.8% of holdings ($45M position)1M shares left1.5x usual sizeFiling

  7. 7 Form 4 sale RPRXPlan not stated
    Jun 8, 2022 +12 days

    Sold 100,000 shares at $41.56 ($4.2M)

    Reddoch James F., EVP & Chief Scientific Officer

    Sold 9.8% of holdings ($42.4M position)920,800 shares left1.9x usual sizeFiling

  8. 8 Form 4 sale RPRXPlan not stated
    Sep 28, 2022 +112 days

    Sold 100,000 shares at $41.23 ($4.1M)

    Reddoch James F., EVP & Chief Scientific Officer

    Sold 10.9% of holdings ($38M position)820,800 shares left1.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Reddoch James F.
Source
Sep 28, 2022Sep 30, 2022RPRXEVP & Chief Scientific OfficerForm 4 sale100,000$4.1M10.9%Plan not statedSEC
Jun 8, 2022Jun 10, 2022RPRXEVP & Chief Scientific OfficerForm 4 sale100,000$4.2M9.8%Plan not statedSEC
May 27, 2022May 31, 2022RPRXEVP & Chief Scientific OfficerForm 4 sale75,000$3.1M6.8%Plan not statedSEC
May 19, 2022May 23, 2022RPRXEVP & Chief Scientific OfficerForm 4 sale75,000$3M6.4%Plan not statedSEC
Jul 26, 2021Jul 27, 2021RPRXEVP, Research & InvestmentsForm 4 sale8,949$356k0.8%Plan not statedSEC
Jul 26, 2021Jul 27, 2021RPRXEVP, Research & InvestmentsForm 4 sale8,949$356k0.8%Plan not statedSEC
Jul 14, 2021Jul 14, 2021RPRXEVP, Research & InvestmentsForm 4 sale17,934$753k1.5%Plan not statedSEC
Jul 8, 2021Jul 8, 2021RPRXEVP, Research & InvestmentsForm 4 sale73,117$3.1M5.8%Plan not statedSEC
Jun 8, 2021Jun 8, 2021RPRXEVP, Research & InvestmentsForm 4 sale200,000$9.1M13.6%UnusualSEC
Jun 2, 2021Jun 4, 2021RPRXEVP, Research & InvestmentsForm 4 sale50,000$2.1M3.3%Plan not statedSEC
Apr 14, 2021Apr 16, 2021RPRXEVP, Research & InvestmentsForm 4 sale55,714$2.3M21.8%Plan not statedSEC
Apr 12, 2021Apr 14, 2021RPRXEVP, Research & InvestmentsForm 4 sale359$15k0.1%Plan not statedSEC
Mar 22, 2021Mar 24, 2021RPRXEVP, Research & InvestmentsForm 4 sale43,927$2M14.6%Plan not statedSEC
Mar 2, 2021Mar 4, 2021RPRXEVP, Research & InvestmentsForm 4 sale100,000$4.7M25.0%UnusualSEC